From: Physical activity and telomere length in early stage breast cancer survivors
Univariate analysis | Multivariate analysis | |||
---|---|---|---|---|
Coefficient (95% CI) | P | Adjusted coefficient (95% CI) | P | |
Physical activity | ||||
Moderate to vigorous (reference) | 1 | 1 | ||
None | −0.27 (−0.08, −0.46) | 0.006 | −0.22 (−0.41, −0.03) | 0.03 |
Age, years | ||||
<55 (reference) | 1 | 1 | ||
55 to 65 | −0.12 (−0.30, 0.07) | 0.22 | −0.09 (−0.28, 0.10) | 0.33 |
>65 | −0.33 (−0.52, −0.13) | 0.001 | −0.26 (−0.47, 0.04) | 0.02 |
Body mass index | ||||
<25 | a1 | |||
25 to 30 | −0.01 (−0.19, 0.16) | 0.88 | ||
>30 | −0.13 (−0.031, 0.05) | 0.16 | ||
Smoking status | ||||
Never (reference) | 1 | |||
Current | −0.11 (−0.52, 0.30) | 0.60 | ||
Previous | −0.09 (−0.24, 0.06) | 0.22 | ||
Race/ethnicity | ||||
White | a1 | |||
Non-white* | −0.03 (−0.22, 0.16) | 0.74 | ||
Educational level | ||||
High school or less | a1 | |||
College | 0.07 (−0.12, 0.26) | 0.48 | ||
Graduate or higher | 0.16 (−0.04, 0.36) | 0.11 | ||
Marital status | ||||
Married/partnered | a1 | |||
Single | −0.02 (−0.18, 0.13) | 0.76 | ||
Stage | ||||
0 and I (reference) | 1 | |||
II | 0.04 (−0.11, 0.20) | 0.58 | ||
III | 0.06 (−0.18, 0.31) | 0.60 | ||
Previous chemotherapy | ||||
No chemotherapy (reference) | 1 | 1 | ||
Chemotherapy | 0.19 (0.04, 0.34) | 0.01 | 0.07 (−0.09, 0.24) | 0.38 |
Current aromatase inhibitor | ||||
None (reference) | ||||
Letrozole | 0.09 (−0.19, 0.38) | 0.53 | ||
Anastrozole | −0.01 (−0.26, 0.23) | 0.93 | ||
Exemestane | 0.03 (−0.28, 0.34) | 0.84 | ||
Cormorbid conditions | ||||
None (reference) | 1 | |||
One | −0.02 (−0.25, 0.21) | 0.86 | ||
Two or more | −0.11 (−0.32, 0.10) | 0.29 | ||
Anxiety | ||||
Normal (reference) | 1 | |||
Symptomatic | −0.01 (−0.18, 0.16) | 0.93 | ||
Depression | ||||
Normal (reference) | 1 | |||
Symptomatic | 0.05 (−0.21, 0.31) | 0.70 |